Evaluation of the effectiveness of lipid-lowering therapy (bile acid sequestrants, niacin, psyllium and lovastatin) for treating hypercholesterolemia in veterans☆
References (26)
- et al.
Medication use and disuse: physician-patient discrepancies
J Chronic Dis
(1975) - et al.
Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions
J Lipid Res
(1970) - et al.
Effect of a modified, well-tolerated niacin regimen on serum total cholesterol, high density lipoprotein cholesterol and the cholesterol to high density lipoprotein ratio
Am J Cardiol
(1989) - et al.
Hepatic toxicity of unmodified and time-release preparations of niacin
Am J Med
(1992) - et al.
Niacin revisited: clinical observations on an important but underutilized drug
Am J Med
(1991) - et al.
Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues of mechanism of action of niacin
Metabolism
(1985) - et al.
Dyslipidemia in veterans. Multiple risk factors may break the bank
Arch Intern Med
(1991) - et al.
Compliance as a determinant of serum digoxin concentration
JAMA
(1973) - et al.
Drug therapy in the elderly
South Med J
(1992) - et al.
Adherence and medication instructions: review and recommendations
J Am Geriatr Soc
(1988)
A general method of compliance assessment using centralized pharmacy records. Description and validation
Med Care
Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge
Clin Chem
The prospective cardiovascular Munster (PROCAM) study: identification of high-risk individuals for myocardial infarction and the role of high-density lipoprotein
Cited by (51)
A "hot" topic in dyslipidemia management-"how to beat a flush": Optimizing Niacin tolerability to promote long-term treatment adherence and coronary disease prevention
2010, Mayo Clinic ProceedingsCitation Excerpt :Immediate-Release Niacin. Nine smaller studies assessed the effects of immediate-release niacin, alone or in combination, on more than 600 patients receiving immediate-release niacin-containing regimens in prospective108–115 and retrospective116 studies. Many involved high starting doses of immediate-release niacin or rapid titration schedules.
Optimal management of hyperlipidemia in primary prevention of cardiovascular disease
2004, International Journal of CardiologyEffect of very-low-dose niacin on high-density lipoprotein in patients undergoing long-term statin therapy
2002, American Heart JournalEffectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: A 24-week randomized controlled trial
2001, Mayo Clinic ProceedingsCitation Excerpt :Patient compliance has an important role in the overall effectiveness of any lipid-lowering treatment regimen.16,34,35 Previous studies have shown that after 1 year of treatment only 37% to 63% of patients continue to take cholestyramine.3,17,36 In the current 6-month study, the overall compliance rate for the colesevelam treatment groups was high (88%-91%) and did not differ significantly from the placebo group (92%).
- ☆
This study was supported by Health Services Research and Delivery #77-33-05P, Veterans Administration, Milwaukee, Wisconsin.